Fundraising FoxHamilton Thorne
Beverly, US · Ontario, Canada corporation
Find your way into Hamilton Thorne
Sign up to see every warm intro you have to Hamilton Thorne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hamilton Thorne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DW
David WolfExecutiveDavid Wolf has held executive and advisory roles across life sciences, technology, business services, distribution, and manufacturing companies, ranging from startups to organizations with annual revenues exceeding $1 billion.
DH
Diarmaid H. Douglas-HamiltonNamed on SEC filing
DT
Daniel ThorneNamed on SEC filing
Board
MS
Meg SpencerBoard director
DG
Dean GendronBoard director
BM
Bruno MaruzzoBoard director
MB
Michael BrunsBoard director
RP
Robert PotterBoard director
Reported raises · per SEC filings
Form D private placements$11.2M disclosed across 4 rounds · 2014–2017
▶$150KraisedOct 2017 · 1 investors · BiotechnologyRule 506(b)
▶$150KraisedOct 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WolfExecutive Officer, Director
- Daniel ThorneDirector
- David SableDirector
- Bruno MaruzzoDirector
- Meg SpencerDirector
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Dean GendronDirector
- Michael BrunsExecutive Officer
- Robert PotterDirector
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Sep 2017
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$9.2MraisedMay 2017 · 21 investors · BiotechnologyRule 506(b)
▶$9.2MraisedMay 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SableDirector
- Daniel ThorneDirector
- Dean GendronDirector
- Michael BrunsExecutive Officer
- Robert PotterDirector
- Meg SpencerDirector
- Bruno MaruzzoDirector
- David WolfExecutive Officer, Director
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Offering amount
- $9.2M
- Amount sold
- $9.2M
- Sales commissions
- $426.9K
- First sale
- Apr 2017
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$1.2MraisedJun 2015 · 17 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJun 2015 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Diarmaid H. Douglas-HamiltonDirector
- Meg SpencerDirector
- Dean GendronDirector
- David WolfExecutive Officer, Director
- Bruno MaruzzoDirector
- Michael BrunsDirector
- Robert PotterDirector
- Daniel ThorneDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- First sale
- Jun 2015
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
▶$660.7KraisedNov 2014 · 16 investors · BiotechnologyRule 506(b)
▶$660.7KraisedNov 2014 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dean GendronDirector
- Diarmaid H. Douglas-HamiltonExecutive Officer, Director
- Robert PotterDirector
- Meg SpencerDirector
- Michael BrunsExecutive Officer
- Daniel ThorneDirector
- Bruno MaruzzoDirector
- David WolfExecutive Officer, Director
- Offering amount
- $660.7K
- Amount sold
- $660.7K
- First sale
- Nov 2014
- Incorporated
- Corporation, Ontario, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Hamilton Thorne raised?
- Hamilton Thorne has disclosed $11.2M raised across 4 rounds.
- Where is Hamilton Thorne headquartered?
- Hamilton Thorne is headquartered in Beverly, US.